[1]
Stone J, Smyth R, Carson A, Warlow C, Sharpe M. La belle indifférence in conversion symptoms and hysteria: systematic review. The British journal of psychiatry : the journal of mental science. 2006 Mar:188():204-9
[PubMed PMID: 16507959]
Level 1 (high-level) evidence
[2]
Ballmaier M, Schmidt R. Conversion disorder revisited. Functional neurology. 2005 Jul-Sep:20(3):105-13
[PubMed PMID: 16324233]
[3]
Khaddafi MR, Amin MM. A Case Series from Rantauprapat, La Belle Indifference: A Coping Mechanism or Is There Something Organic Behind? Open access Macedonian journal of medical sciences. 2019 Aug 30:7(16):2675-2678. doi: 10.3889/oamjms.2019.405. Epub 2019 Aug 28
[PubMed PMID: 31777632]
Level 2 (mid-level) evidence
[5]
Hamner MB, Lorberbaum JP, George MS. Potential role of the anterior cingulate cortex in PTSD: review and hypothesis. Depression and anxiety. 1999:9(1):1-14
[PubMed PMID: 9989344]
[6]
Bourgeois JA, Chang CH, Hilty DM, Servis ME. Clinical Manifestations and Management of Conversion Disorders. Current treatment options in neurology. 2002 Nov:4(6):487-497
[PubMed PMID: 12354375]
[7]
Hurwitz TA. Somatization and conversion disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2004 Mar:49(3):172-8
[PubMed PMID: 15101499]
[8]
Holmes EA, Brown RJ, Mansell W, Fearon RP, Hunter EC, Frasquilho F, Oakley DA. Are there two qualitatively distinct forms of dissociation? A review and some clinical implications. Clinical psychology review. 2005 Jan:25(1):1-23
[PubMed PMID: 15596078]
Level 2 (mid-level) evidence
[9]
Sar V, Akyüz G, Kundakçi T, Kiziltan E, Dogan O. Childhood trauma, dissociation, and psychiatric comorbidity in patients with conversion disorder. The American journal of psychiatry. 2004 Dec:161(12):2271-6
[PubMed PMID: 15569899]
[10]
Folks DG, Ford CV, Regan WM. Conversion symptoms in a general hospital. Psychosomatics. 1984 Apr:25(4):285-9, 291, 294-5
[PubMed PMID: 6718664]
[11]
Asadi-Pooya AA, Sperling MR. Epidemiology of psychogenic nonepileptic seizures. Epilepsy & behavior : E&B. 2015 May:46():60-5. doi: 10.1016/j.yebeh.2015.03.015. Epub 2015 Apr 14
[PubMed PMID: 25882323]
[12]
Duncan R, Razvi S, Mulhern S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy & behavior : E&B. 2011 Feb:20(2):308-11. doi: 10.1016/j.yebeh.2010.10.022. Epub 2010 Dec 30
[PubMed PMID: 21195031]
[13]
Stefánsson JG, Messina JA, Meyerowitz S. Hysterical neurosis, conversion type: clinical and epidemiological considerations. Acta psychiatrica Scandinavica. 1976 Feb:53(2):119-38
[PubMed PMID: 1251758]
Level 2 (mid-level) evidence
[14]
Bodde NM, Brooks JL, Baker GA, Boon PA, Hendriksen JG, Aldenkamp AP. Psychogenic non-epileptic seizures--diagnostic issues: a critical review. Clinical neurology and neurosurgery. 2009 Jan:111(1):1-9. doi: 10.1016/j.clineuro.2008.09.028. Epub 2008 Nov 18
[PubMed PMID: 19019531]
[15]
Deka K, Chaudhury PK, Bora K, Kalita P. A study of clinical correlates and socio-demographic profile in conversion disorder. Indian journal of psychiatry. 2007 Jul:49(3):205-7. doi: 10.4103/0019-5545.37323. Epub
[PubMed PMID: 20661388]
[16]
Feinstein A. Conversion disorder: advances in our understanding. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2011 May 17:183(8):915-20. doi: 10.1503/cmaj.110490. Epub 2011 Apr 18
[PubMed PMID: 21502352]
Level 3 (low-level) evidence
[17]
Carson AJ, Ringbauer B, MacKenzie L, Warlow C, Sharpe M. Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department. Journal of neurology, neurosurgery, and psychiatry. 2000 Feb:68(2):202-6
[PubMed PMID: 10644788]
[18]
Roelofs K, Pasman J. Stress, childhood trauma, and cognitive functions in functional neurologic disorders. Handbook of clinical neurology. 2016:139():139-155. doi: 10.1016/B978-0-12-801772-2.00013-8. Epub
[PubMed PMID: 27719835]
[19]
O'Neal MA, Baslet G. Treatment for Patients With a Functional Neurological Disorder (Conversion Disorder): An Integrated Approach. The American journal of psychiatry. 2018 Apr 1:175(4):307-314. doi: 10.1176/appi.ajp.2017.17040450. Epub
[PubMed PMID: 29606068]
[20]
Mehndiratta MM, Kumar M, Nayak R, Garg H, Pandey S. Hoover's sign: Clinical relevance in Neurology. Journal of postgraduate medicine. 2014 Jul-Sep:60(3):297-9. doi: 10.4103/0022-3859.138769. Epub
[PubMed PMID: 25121372]
[21]
Daum C, Hubschmid M, Aybek S. The value of 'positive' clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review. Journal of neurology, neurosurgery, and psychiatry. 2014 Feb:85(2):180-90. doi: 10.1136/jnnp-2012-304607. Epub 2013 Mar 6
[PubMed PMID: 23467417]
Level 3 (low-level) evidence
[22]
van der Stouwe AM, Elting JW, van der Hoeven JH, van Laar T, Leenders KL, Maurits NM, Tijssen MA. How typical are 'typical' tremor characteristics? Sensitivity and specificity of five tremor phenomena. Parkinsonism & related disorders. 2016 Sep:30():23-8. doi: 10.1016/j.parkreldis.2016.06.008. Epub 2016 Jun 16
[PubMed PMID: 27346607]
[23]
Dickinson P, Looper KJ. Psychogenic nonepileptic seizures: a current overview. Epilepsia. 2012 Oct:53(10):1679-89. doi: 10.1111/j.1528-1167.2012.03606.x. Epub 2012 Aug 6
[PubMed PMID: 22882112]
Level 3 (low-level) evidence
[24]
Duncan R, Oto M. Predictors of antecedent factors in psychogenic nonepileptic attacks: multivariate analysis. Neurology. 2008 Sep 23:71(13):1000-5. doi: 10.1212/01.wnl.0000326593.50863.21. Epub
[PubMed PMID: 18809836]
[25]
Ford CV, Folks DG. Conversion disorders: an overview. Psychosomatics. 1985 May:26(5):371-4, 380-3
[PubMed PMID: 2581282]
Level 3 (low-level) evidence
[26]
Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosomatic medicine. 2007 Dec:69(9):889-900
[PubMed PMID: 18040100]
[27]
Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosomatic medicine. 2007 Dec:69(9):881-8
[PubMed PMID: 18040099]
Level 1 (high-level) evidence
[28]
Goldstein LH, Deale AC, Mitchell-O'Malley SJ, Toone BK, Mellers JD. An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology. 2004 Mar:17(1):41-9
[PubMed PMID: 15209224]
Level 3 (low-level) evidence
[29]
Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. The Journal of clinical psychiatry. 2005 Dec:66(12):1529-34
[PubMed PMID: 16401153]
[30]
Feinstein A, Stergiopoulos V, Fine J, Lang AE. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry, neuropsychology, and behavioral neurology. 2001 Jul-Sep:14(3):169-76
[PubMed PMID: 11513100]
[31]
Stone J, Smyth R, Carson A, Lewis S, Prescott R, Warlow C, Sharpe M. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ (Clinical research ed.). 2005 Oct 29:331(7523):989
[PubMed PMID: 16223792]
Level 1 (high-level) evidence
[32]
Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012 Jul 17:79(3):282-4. doi: 10.1212/WNL.0b013e31825fdf63. Epub 2012 Jul 3
[PubMed PMID: 22764261]
[33]
Baslet G, Seshadri A, Bermeo-Ovalle A, Willment K, Myers L. Psychogenic Non-epileptic Seizures: An Updated Primer. Psychosomatics. 2016 Jan-Feb:57(1):1-17. doi: 10.1016/j.psym.2015.10.004. Epub 2015 Oct 22
[PubMed PMID: 26791511]